<DOC>
<DOCNO>
EP-0013784
</DOCNO>
<TEXT>
<DATE>
19800806
</DATE>
<IPC-CLASSIFICATIONS>
C07C-309/51 C07C-309/00 A61K-6/02 A61K-31/185 A61K-7/22 C07C-309/50 A61Q-11/00 <main>C07C-143/675</main> A61K-8/30 A61K-8/46 
</IPC-CLASSIFICATIONS>
<TITLE>
c-substituted naphthalenemonosulfonic ureides, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
american cyanamid co<sep>american cyanamid company<sep>american cyanamid companyberdan avenuewayne new jersey 06904us<sep>american cyanamid company  <sep>
</APPLICANT>
<INVENTOR>
bernstein seymour<sep>bernstein, seymour<sep>bernstein, seymour26 scott drivenew city new york, 10956us<sep>bernstein, seymour<sep>bernstein, seymour26 scott drivenew city new york, 10956us<sep>
</INVENTOR>
<ABSTRACT>
the invention provides novel c-substituted naphtha­ lenemonosulfonic ureides and pharmaceutical composi­ tions containing them.  the novel compounds of the inven­ tion have the formula:    wherein a is hydrogen or a pharmaceutically acceptable  salt cation; b is hydrogen, lower (c₁-c₆) alkanoyl or alkali  metal; and r is hydrogen or lower (c₁-c₃) alkyl.  the present novel compounds are especially useful  for inhibiting connective tissue destruction in warm-blood­ ed animals and for such purpose may be formulated with  pharmaceutically acceptable carriers or diluents e. g.  to  form dental creams and pastes.  
</ABSTRACT>
</TEXT>
</DOC>
